Search results for "Isoniazid"

showing 10 items of 24 documents

Synthesis of polymeric derivatives of isoniazid: characterization and in vitro release from a water-soluble adduct with polysuccinimide.

1989

Coupling of isoniazid with polysuccinimide afforded a water-insoluble polymeric pro-drug; by reaction with ethanolamine it was chemically transformed in a water-soluble adduct. The in vitro release of isoniazid from the drug-polymer adduct was studied by using an artificial stomach wall lipid membrane. The transfer rate constant from simulated gastric juice to simulated plasma was defined and compared with that of an equivalent dose of pure drug.

Absorption of waterChemistryChemistry PharmaceuticalIsoniazidSuccinimidesGeneral ChemistryGeneral MedicineIn vitroAdductchemistry.chemical_compoundWater solubleEthanolamineSolubilityDrug DiscoverymedicineIsoniazidOrganic chemistryLipid bilayerTransfer rate constantmedicine.drugNuclear chemistryChemicalpharmaceutical bulletin
researchProduct

Genotype and allele frequencies of isoniazid-metabolizing enzymes NAT2 and GSTM1 in Latvian tuberculosis patients

2016

Pharmacogenomic testing of tuberculosis drug-metabolizing enzyme genes was proposed as a strategy to identify patients at risk for suboptimal responses to medications. However, variations of the genotype frequencies among ethnic groups exist and new alleles are been identified. The aim of this study was to identify polymorphisms of genes encoding metabolic enzymes NAT2 and GSTM1 in tuberculosis patients in Latvia and to estimate the frequency of NAT2 slow acetylator and GSTM1 null genotypes. In total, 85 DNA samples were genotyped, all individuals were Caucasian. An ethnic heterogeneity reflecting the multiethnic population of the country was observed. 49 patients were Latvians, 30 were Rus…

AdultMale0301 basic medicineMicrobiology (medical)TuberculosisGenotypeArylamine N-AcetyltransferaseAntitubercular AgentsBiologyYoung Adult03 medical and health sciencesGene FrequencyGenotypeIsoniazidmedicineHumansTuberculosisPharmacology (medical)AlleleGenotypingAllele frequencyAgedGlutathione TransferaseGeneticsPolymorphism GeneticIsoniazidMiddle Agedmedicine.diseaseLatviaGenotype frequency030104 developmental biologyInfectious DiseasesFemalePharmacogeneticsmedicine.drugJournal of Infection and Chemotherapy
researchProduct

Molecular epidemiology of tuberculosis in Sicily, Italy: what has changed after a decade?

2014

Background We aimed to investigate the molecular epidemiology of Mycobacterium tuberculosis complex (MTBC) isolates in the province of Palermo, Sicily, Italy, by characterizing 183 isolates identified in the years 2004-2012. A comparison with 104 MTBC strains identified in the same geographic area in the years 1994-2000 was also carried out. Methods One hundred eighty-three MTBC isolates identified in Palermo, Italy, in the years 2004-2012 were analyzed by spoligotyping and the 24 mycobacterial interspersed repetitive unit (MIRU)-variable-number tandem-repeat (VNTR) method typing. Susceptibility testing to streptomycin, isoniazid, rifampin and ethambutol was also performed. Furthermore, the…

AdultMaleSettore MED/07 - Microbiologia E Microbiologia ClinicaVeterinary medicineTuberculosis Sicily Epidemiology Spoligotyping MIRU-VNTRTuberculosisGenotypeEpidemiologyLineage (evolution)Microbial Sensitivity TestsMinisatellite RepeatsSettore MED/42 - Igiene Generale E ApplicataMIRU-VNTRDrug Resistance BacterialIsoniazidMedicineTuberculosisHumansTypingSicilyAntibiotics AntitubercularEthambutolSpoligotypingMolecular EpidemiologyMolecular epidemiologybiologybusiness.industryMycobacterium tuberculosisMiddle Agedmedicine.diseasebiology.organism_classificationMolecular TypingInfectious DiseasesParasitologyMycobacterium tuberculosis complexStreptomycinFemaleRifampinbusinessEthambutolmedicine.drugResearch ArticleBMC Infectious Diseases
researchProduct

[Tuberculosis epidemiology in area 15 of the Spanish autonomous community of Valencia: evolution from 1987 through 2001].

2005

Objectives TO describe the evolution of tuberculosis epidemiology in Area 15 of the Autonomous Community of Valencia. Material and Methods Cases of tuberculosis were identified by active case finding in Area 15 from January 1987 through December 2001. Clinical and epidemiological data were extracted from case records and a patient interview. Results Four hundred seventy-six diagnosed cases of mycobacterial infection were identified (459 tuberculosis, 16 atypical, and 1 mixed); 423 tuberculosis patients were residents of Area 15. The mean annual incidence rate was 24.6/100 000 population, representing a rate decrease of 41.5% from 1990. The most frequent risk factors were smoking (38%), alco…

AdultMalemedicine.medical_specialtyTuberculosisTime FactorsAdolescentPopulationAntitubercular AgentsHIV InfectionsAnnual incidenceCohort StudiesSex FactorsRisk FactorsInternal medicinePandemicEpidemiologymedicineHumansTuberculosiseducationChildTuberculosis PulmonaryAgededucation.field_of_studyLungbusiness.industryIncidence (epidemiology)SmokingAge FactorsInfant NewbornInfantGeneral MedicineIsoniazid resistanceLength of StayMiddle Agedmedicine.diseaseHospitalizationAlcoholismmedicine.anatomical_structureSpainChild PreschoolImmunologyFemaleRadiography ThoracicbusinessArchivos de bronconeumologia
researchProduct

Mechanistic and kinetic insight into spontaneous cocrystallisation of isoniazid and benzoic acid

2015

Solid-state cocrystallisation is of contemporary interest, because it offers an easy and efficient way to produce cocrystals, which are recognized as prospective pharmaceutical materials. Research explaining solid-state cocrystallisation mechanisms is important, but still too scarce to give a broad understanding of factors governing and limiting these reactions. Here we report an investigation of the mechanism and kinetics of isoniazid cocrystallisation with benzoic acid. This reaction is spontaneous; however its rate is greatly influenced by environmental conditions (humidity and temperature) and pre-treatment (milling) of the sample. The acceleration of cocrystallisation in the presence o…

ChemistryChemistry PharmaceuticalIsoniazidKineticsPharmaceutical Sciencefood and beveragesLimitingBenzoic AcidCocrystalKineticschemistry.chemical_compoundDrug StabilitySolubilityX-Ray DiffractionMechanism (philosophy)MechanochemistryDrug DiscoveryIsoniazidmedicineThermodynamicsMolecular MedicineOrganic chemistryCrystallizationmedicine.drugBenzoic acid
researchProduct

Spectrofluorimetric Determination of Iproniazid and Isoniazid in a FIA System Provided with a Solid-Phase Reactor

1998

Abstract A FIA assembly is proposed for the fluorimetric determination of iproniazid and isoniazid. The oxidation of both drugs is carried out by H2O2. The excess of reagent is destroyed and removed from the flow-injection manifold by means of a metallic copper reactor which acts as catalyst in the decomposition of H2O2 and a home made debubbler. The calibration graphs were linear up to 14 μg ml−1 and 10 μg ml−1 (n=6) for iproniazid and isoniazid, respectively, with limits of detection of 0.008 μg ml−1 and 0.005 μg ml−1. The sample throughput was 24 h−1 for both drugs. The influence of foreign compounds was studied and the procedure was applied to determination of iproniazid and isoniazid i…

Detection limitChromatographyChemistryBiochemistry (medical)Clinical BiochemistryIsoniazidFluorescence spectrometryBiochemistryDosage formAnalytical ChemistryIproniazidReagentPhase (matter)ElectrochemistrymedicineQuantitative analysis (chemistry)Spectroscopymedicine.drugAnalytical Letters
researchProduct

Determination of isoniazid and pyridoxine in plasma sample of tuberculosis patients by micellar liquid chromatography

2021

It is no doubt Isoniazid is a powerful tuberculosis drug, but it might give rise to Vitamin B6 (Pyridoxine) deficiency. In this case, a usual treatment is the combined administration of Isoniazid and Pyridoxine. An easy-to-conduct procedure based on Micellar Liquid Chromatography has been developed to quantify Isoniazid and Pyridoxine in plasma from Tuberculosis patients. The sample was diluted in mobile phase, filtered and directly injected, thus avoiding extraction or purification steps. Both drugs were adequately resolved from the matrix and endogenous compounds using a mobile phase made up of 0.15 M sodium dodecyl sulfate – 8%(v/v) 1-butanol – 0.01 M phosphate buffer at pH 3, running at…

DrugBioanalysismedia_common.quotation_subjectmicellar02 engineering and technology01 natural sciencespatientsAnalytical ChemistryMatrix (chemical analysis)chemistry.chemical_compoundmedicineantituberculosisSodium dodecyl sulfateSpectroscopyplasmamedia_commonChromatographyChemistry010401 analytical chemistryExtraction (chemistry)Isoniaziddrug021001 nanoscience & nanotechnologyPyridoxine0104 chemical sciencesMicellar liquid chromatography0210 nano-technologyoptimizationmedicine.drug
researchProduct

Detection of oxidative mutagenesis by isoniazid and other hydrazine derivatives in Escherichia coli WP2 tester strain IC203, deficient in OxyR: stron…

1998

Abstract Strain IC203, deficient in the OxyR function, was sensitive to both cytotoxic and mutagenic effects of isoniazid (INH) whereas its parent, WP2 uvrA /pKM101, was resistant to these effects. Four other hydrazine compounds, hydrazine hydrate (HZH), phenylhydrazine (PHZ), hydralazine (HLZ) and nialamide (NLD), were mutagenic in WP2 uvrA /pKM101. Increases in mutagenicity were observed in IC203 for HZH and PHZ but not for HLZ and NLD. Growth inhibition zones by HZH, PHZ and NLD were larger in IC203 than in WP2 uvrA /pKM101. The enhancements in the effects of INH, HZH and PHZ in IC203 with respect to its oxyR + parent are considered to be caused by the production of reactive oxygen speci…

Health Toxicology and Mutagenesismedicine.disease_causechemistry.chemical_compoundSpecies SpecificityEscherichia coliIsoniazidGeneticsmedicineAnimalsEscherichia coliPhenylhydrazinechemistry.chemical_classificationReactive oxygen speciesbiologyMutagenicity TestsEscherichia coli ProteinsMutagenesisbiology.organism_classificationEnterobacteriaceaeRatsDNA-Binding ProteinsRepressor ProteinsLiverBiochemistrychemistryMutagenesisCatalasebiology.proteinbacteriaGrowth inhibitionReactive Oxygen SpeciesOxidation-ReductionCytosineMutagensTranscription FactorsMutation Research/Genetic Toxicology and Environmental Mutagenesis
researchProduct

Janus -faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection

2012

We have generated unique asymmetric liposomes with phosphatidylserine (PS) distributed at the outer membrane surface to resemble apoptotic bodies and phosphatidic acid (PA) at the inner layer as a strategy to enhance innate antimycobacterial activity in phagocytes while limiting the inflammatory response. Results show that these apoptotic body-like liposomes carrying PA (ABL/PA) ( i ) are more efficiently internalized by human macrophages than by nonprofessional phagocytes, ( ii ) induce cytosolic Ca 2+ influx, ( iii ) promote Ca 2+ -dependent maturation of phagolysosomes containing Mycobacterium tuberculosis (MTB), ( iv ) induce Ca 2+ -dependent reactive oxygen species (ROS) production, (…

MaleAntitubercular AgentsApoptosisSettore MED/07Mice0302 clinical medicineInnateInbred BALB CMycobacterium tuberculosis liposomes0303 health sciencesMice Inbred BALB CMultidisciplinaryLeukemiaTumorbiologyMacrophages; Leukemia Monocytic Acute; Animals; Apoptosis; Calcium; Humans; Disease Models Animal; Mice; Cell Line Tumor; Immunity Innate; Reactive Oxygen Species; Mice Inbred BALB C; Liposomes; Phosphatidylserines; Tuberculosis Pulmonary; Adult; Bronchoalveolar Lavage Fluid; Middle Aged; Antitubercular Agents; Phagocytosis; Male; Mycobacterium tuberculosis; IsoniazidInterleukinPulmonaryMiddle AgedSettore BIO/193. Good healthPNAS PlusLeukemia Monocytic AcuteTumor necrosis factor alphaBronchoalveolar Lavage FluidIntracellularAdultPhagocytosisPhosphatidylserinesAcutePhagolysosomeSettore MED/07 - MICROBIOLOGIA E MICROBIOLOGIA CLINICAMicrobiologyCell LineMycobacterium tuberculosis03 medical and health sciencesPhagocytosisCell Line TumorIsoniazidTuberculosisAnimalsHumansTuberculosis Pulmonary030304 developmental biologySettore MED/04 - Patologia GeneraletherapyInnate immune systemMonocyticAnimalMacrophagesImmunityMycobacterium tuberculosisbiology.organism_classificationImmunity InnateDisease Models AnimalApoptosisImmunologyDisease ModelsLiposomesCalciumReactive Oxygen Species030215 immunology
researchProduct

Clinicopathological profile of gastrointestinal tuberculosis: a multinational ID-IRI study

2020

Data are relatively scarce on gastro-intestinal tuberculosis (GITB). Most studies are old and from single centers, or did not include immunosuppressed patients. Thus, we aimed to determine the clinical, radiological, and laboratory profiles of GITB. We included adults with proven GITB treated between 2000 and 2018. Patients were enrolled from 21 referral centers in 8 countries (Belgium, Egypt, France, Italy, Kazakhstan, Saudi Arabia, UK, and Turkey). One hundred four patients were included. Terminal ileum (n = 46, 44.2%), small intestines except terminal ileum (n = 36, 34.6%), colon (n = 29, 27.8%), stomach (n = 6, 5.7%), and perianal (one patient) were the sites of GITB. One-third of all p…

MaleCirrhosismedicine.medical_treatmentretrospective studylaparoscopyColonoscopymultimodal imagingComorbidityGastroenterologyprotionamide0302 clinical medicineLaparotomyAscitesamikacinMedicinebedaquilinePathologie maladies infectieusesintestine biopsyadultsteroidclinical trialGeneral MedicinerifabutinMicrobiologie et protistologie [entomologiephytoparasitolog.]priority journaldiabetes mellitushistopathologybiological productMicrobiology (medical)Microbiologie et protistologie [parasitologie hum. et anim.]medicine.medical_specialtyTuberculosis030106 microbiologymalignant neoplasmArticle03 medical and health scienceslaparotomyHuman immunodeficiency virus infectionmolecular diagnosisHumansTuberculosisGastro-intestinalhumanRetrospective Studiescolondisease predispositionmicrobiologyTuberculosis; Immune-suppression; Gastro-intestinal; Endoscopy;anusmedicine.diseasemajor clinical studymulticenter studyaminosalicylic acidcyclophosphamide0301 basic medicineBiopsyAntitubercular Agentsethambutolrifampicinterminal ileumcolonoscopyofloxacin030212 general & internal medicineLaparoscopyazathioprinemedicine.diagnostic_testIncidence (epidemiology)gastrointestinal tuberculosisDisease Managementchronic kidney failurecycloserineInfectious DiseasesfemaleTreatment OutcomeMolecular Diagnostic Techniquesdiagnostic testDisease Susceptibilitymedicine.symptommoxifloxacinSymptom AssessmentImmune-suppressionstomachisoniazidpyrazinamidestreptomycinliver cirrhosispatient referrallinezolidInternal medicineBiopsybusiness.industryEndoscopyMycobacterium tuberculosishuman tissueclinical featureTreatmentTuberculosis Gastrointestinaltuberculostatic agentbusinessMicrobiologie et protistologie [bacteriol.virolog.mycolog.]
researchProduct